Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients

Journal of Neurology

Volumn 257, Issue 3, 2010, Pages 459-460

  Jamrozik, Zygmunt ^a   Lugowska, Agnieszka ^b   Slawek, Jaroslaw ^c,d   Kwiecinski, Hubert ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d ST ADALBERT HOSPITAL   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCOSYLCERAMIDASE; GENOMIC DNA; GLUCOSYLCERAMIDASE; UNCLASSIFIED DRUG;

BRAIN ATROPHY; CORTICOBASAL DEGENERATION; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY; HUMAN; INCIDENCE; LETTER; MOTOR DYSFUNCTION; MULTISYSTEM ATROPHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

DNA MUTATIONAL ANALYSIS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; GLUCOSYLCERAMIDASE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MULTIPLE SYSTEM ATROPHY; MUTATION; POLAND; RISK FACTORS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 77951204198     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5363-4     Document Type: Letter

References (10)

1. J Aharon-Peretz H Rosenbaum R Gershoni-Baruch 2004 Mutations in glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews N Engl J Med 351 1972 1977 10.1056/NEJMoa033277 10.1056/NEJMoa033277 15525722 1:CAS:528:DC%2BD2cXps1Wksbc%3D (Pubitemid 39447138)
2. IF Mata A Samii SH Achneer JW Roberts A Griffith BC Leis GD Schellenberg E Sidransky TD Bird JB Leverenz, et al. 2008 Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders Arch Neurol 65 379 382 10.1001/archneurol.2007.68 10.1001/archneurol.2007.68 18332251 (Pubitemid 351398524)
3. Bras J, Paisan-Ruiz C, Guerreiro R, Ribeiro MH, Morgadinho A, Januario C, Sidransky E, Oliveira C, Singelton A (2007) Complete screening for glucocerebrosidase mutations in Parkinson's disease patients from Portugal. Neurobiol Aging. doi: 10.1016/neurobiolaging.2007.11.016
4. J Bras A Singleton MR Cookson J Hardy 2008 Emerging pathways is genetic Parkinson's disease: potential role of ceramide metabolism in Lewy body disease FEBS J 275 5767 5773 10.1111/j.1742-4658.2008.06709.x 10.1111/j.1742-4658.2008. 06709.x 19021754 1:CAS:528:DC%2BD1cXhsV2mur3I
5. DR Williams AJ Lees 2009 Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges Lancet Neurol 3 270 279 10.1016/S1474-4422(09)70042-0 10.1016/S1474-4422(09)70042-0
6. N Tayebi J Walker B Stubblefield E Orvisky ME LaMarca K Wong H Rosenbaum R Schiffmann B Bembi E Sidransky 2003 Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79 104 109 10.1016/S1096-7192(03)00071-4 10.1016/S1096-7192(03)00071-4 12809640 1:CAS:528:DC%2BD3sXksVGlt78%3D (Pubitemid 36693928)
7. U Gutti H-C Fung KS Hruska ME LaMarca C-M Chen Y-R Wu E Sidransky 2008 The need for appropriate genotyping strategies for glucocerebrosidase mutations in cohort with Parkinson's disease Arch Neurol 65 6 850 851 10.1001/archneur.65. 6.850 10.1001/archneur.65.6.850 18541817 (Pubitemid 351831475)
8. O Goker-Alpan G Lopez J Vithayathil J Davis M Hallett E Sidransky 2008 The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations Arch Neurol 65 10 1353 1357 10.1001/archneur.65.10.1353 10.1001/archneur.65.10.1353 18852351
9. B Segarane A Li R Paudel S Scholz J Neumann A Lees T Revesz J Hardy CJ Mathias NW Wood J Holton H Houlden 2009 Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy Neurology 72 1185 1186 10.1212/01.wnl.0000345356.40399.eb 10.1212/01.wnl.0000345356.40399.eb 19332698 1:STN:280:DC%2BD1M3ksFSjtQ%3D%3D
10. RM Abidhatia JF Hatcher 2008 Altered lipid metabolism in brain injury and disorders Subcell Biochem 49 241 268 10.1007/978-1-4020-8831-5-9 10.1007/978-1-4020-8831-5-9